Go Back to People

Timothy P. Coleman

Ph.D. MBA - CEO & President

Tim has been in the industry for 10 years and was recently the leader of the Biomedical Strategy Group in PricewaterhouseCoopers.  Prior to joining PwC, Dr. Coleman was president, CEO and co-founder of BioCache Pharmaceuticals, Inc., a Richmond, Virginia-based biopharmaceutical company primarily engaged in the research and development of cancer vaccines. There, he was a National Cancer Institute funded principal investigator studying the interaction of cancer vaccines with Toll-Like Receptors (TLRs) to induce a clinically relevant immune response.  Additionally, he successfully led the firm’s growth through early stage funding, strategic expansion and eventual establishment of a non-founding executive leadership team.